Quick Answer
Gossamer Bio, Inc. reported Earnings Per Share Diluted of $0.75 (loss) per share for the year ending 2025.
- Gossamer Bio, Inc. showed a decrease of -200.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Gossamer Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $0.87 (loss) per share | Q2 2020: $1.00 (loss) per share | Q3 2020: $0.80 (loss) per share | Q1 2021: $0.78 (loss) per share | Q2 2021: $0.80 (loss) per share | Q3 2021: $0.80 (loss) per share | Q1 2022: $0.76 (loss) per share | Q2 2022: $0.74 (loss) per share | Q3 2022: $0.65 (loss) per share | Q1 2023: $0.52 (loss) per share | Q2 2023: $0.45 (loss) per share | Q3 2023: $0.21 (loss) per share | Q1 2024: $0.19 (loss) per share | Q2 2024: $0.22 per share | Q3 2024: $0.14 (loss) per share | Q1 2025: $0.16 (loss) per share | Q2 2025: $0.17 (loss) per share | Q3 2025: $0.21 (loss) per share.
- Over the full 7 years of available data (2019 to 2025), Gossamer Bio, Inc.'s Earnings Per Share Diluted has grown by 77.2%.
- Historical annual values: Fiscal year 2025: $0.75 (loss) per share | Fiscal year 2024: $0.25 (loss) per share | Fiscal year 2023: $1.18 (loss) per share | Fiscal year 2022: $2.71 (loss) per share | Fiscal year 2021: $3.13 (loss) per share | Fiscal year 2020: $3.55 (loss) per share | Fiscal year 2019: $3.29 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: